vTv Therapeutics Prices ~7.812M Share IPO @$15.00/Share

vTv Therapeutics Inc.

announced today the pricing of its initial public offering of 7,812,500 shares of its Class A common stock at a price to the public of $15.00 per share. All of the shares are being offered by the Company. In addition, the Company has granted the underwriters an option to purchase up to an additional 1,171,875 shares of Class A common stock. The shares of Class A common stock are expected to begin trading on the Nasdaq Global Market on July 30, 2015, under the symbol "VTVT." The Company intends to use the net proceeds of the offering to fund the STEADFAST Study (its ongoing Phase 3 trial of azeliragon, a drug candidate for